The Medtronic-covidien Mergera Post-mortem Analysis
The Medtronic-Covidien MergerA Post-Mortem Analysis Bryan Hughes, P&M Corporate Finance07.20.16 For much of the past decade, medical device companies have reshaped their businesses through acquisitions, divestitures, and portfolio realignment. As the realities of the Affordable Care Act, payer and provider consolidation, and continued pricing pressure (along with other headwinds) have become more transparent, medical device firms have sought to offset declining growth through multiple non-organic means. No event over the last two years illustrates the rationale and downstream consequences of this strategy quite as acutely as Medtronic plcs acquisition of Covidien. On an otherwise quiet summer weekend in 2014, the two companies shocked the medical device community by announcing a $42.9 billion merger. The mere size of the transaction moved Medtronic up two spots on Medical Product Outsourcings annual ranking of the 30 largest medical device companies, surpassing both GE and Siemens. The company now trails only Johnson & Johnson, itself transformed through multiple acquisitions and divestitures, in the most recent ranking. Industry analysts applauded the Covidien transaction, which built upon three key tenetstherapy innovation, globalization, and economic value. In prepared remarks, Covidiens then CEO Joe Almeida stated, Covidien and Medtronic, when combined, will provide patients, physicians, and hospitals with a compelling portfolio of offerings that will help improve care and surgical performance. This transaction provides our shareholders with immediate value and the opportunity to participate in the significant upside potential of the combined organization. Much of this promise has proven out; the transaction truly was transformational, affording shareholders the va Continue reading >>
Update On Minimed 670g Availability
Today, I’m excited to share that we’re rolling out the MiniMed 670G system, beginning with those in the Priority Access program. But before we get into details, on behalf of the entire Medtronic team, I want to extend both my gratitude and my commitment to you. First, thank you for your enthusiasm for this new technology. We’re incredibly inspired by the many positive stories from those who’ve experienced the system (like Nicky and John) – either in the clinical trial or the initial Customer Training Phase – and from the anticipation expressed by our community. We are honored and humbled by the opportunity to contribute to a big change in your life with diabetes. Thank you also for your patience. We know the rollout of this first-of-its-kind technology is taking time. We’re doing our best to process orders and provide training as quickly as possible. However, the demand for the product surpassed even our own expectations. And we strongly believe that ensuring you have a great experience is more important than speed. With its exclusive SmartGuard HCL technology, the MiniMed 670G system takes a more active role in diabetes management than any technology that’s come before it. The system automatically adjusts basal insulin delivery throughout the day to maintain stable glucose levels. As a result, we’re seeing people spending more Time in Range and less time thinking about their diabetes, which is fantastic! But that also means it’s more critical than ever that each person who goes on the system and their healthcare team is comfortable. Even if it requires a little more time and patience from both of us. This is where our commitment comes in. Our first and foremost commitment to you is that we’ll do everything we can to ensure you have a great experie Continue reading >>
Medtronic, K2m Group Stocks Topple After Hurricanes Impact Sales | Stock News & Stock Market Analysis - Ibd
Hurricanes Harvey, Irma and Maria didn't just devastate Texas, Florida and Puerto Rico: Medtech players Medtronic ( MDT ), K2M Group ( KTWO ) and Wright Medical Group ( WMGI ) were flailing in the headwinds on Monday. XIn afternoon trading on the stock market today , IBD's 116-company Medical-Products industry group, which Medtronic leads by market cap, fell a collective 1.1% after K2M and Medtronic acknowledged the impact the hurricanes had on their quarterly metrics. But they won't be alone, RBC analyst Glenn Novarro wrote in a note to clients. News reports indicate 70% of Puerto Rico's hospitals were not operational at the end of the third quarter. Those that were operational may not have been running at full capacity, he said. "We assume two lost weeks of procedures at the end of the third quarter (in Puerto Rico) for device manufacturers," he said. "Also, we conservatively estimate that no elective procedures will be performed in Puerto Rico in the fourth quarter." On Friday, Medtronic said it expected a $250 million impact to both revenue and earnings in its fiscal second quarter. The firm said it's too early to determine whether there will be an impact in the latter half of the year. At least three analysts cut their price targets on the stock. K2M followed Medtronic on Monday, pre-announcing negative Q3 results and sustaining at least two price-target haircuts. For the quarter, K2M expects to report $62.7 million in sales, up 6% vs. the year-earlier period, but below analysts' views for $67 million. The firm also trimmed its 2017 sales outlook to $255 million to $257 million, which would grow 8% to 9%. Shares of K2M were among those hardest hit in the Medical-Products group, plunging 18.4% to close at 17.77 Monday. Wright,NuVasive ( NUVA ) and Globus Medical ( Continue reading >>
Ordering And Billing | Eshop Support - Medtronic Diabetes Uk
Related Supplies (IV Preps, tape, pump batteries) *Please be aware, if you would like to self-fund Continuous Glucose Monitoring, confirmation from your health care provider agreeing to support your care is still needed. Please contact your Hospital to discuss before ordering goods. If you are looking for a product but you cannot find it our online product catalogue, please contact us and we will be happy to discuss your requirements. How long does it take to set up an account? If you are a new customer, our turnaround time to set up your account is 2-3 business days from the moment we have received the funding account registration form from your healthcare provider. Do you have questions regarding your funded account? Call us at +44 (0)1923 202 564 Monday through Friday from 8:30 AM 5:00 PM GMT. Changing doctor / Change in your prescription? If you change doctors or your prescription changes, please let us know so we can update your records. Call +44 (0)1923 202 531 Monday through Friday from 8:30 am 5:30 pm GMT. Please allow up to 3 days for your supply orders to be processed. During this time we will verify your funding to ensure proper billing before your order is shipped. All online orders will be shipped free of charge with TNT 2 Day delivery. In case of emergency, please call +44 (0)1923 205 167 and select option 1 Monday through Friday from 8:30 am 5:30 pm GMT to speak to a Customer Service Representative about your options. Check the status of your order 24 hours a day by signing in to your personal account on the Store. Once you have signed in, click on the Order History tab. If you have recent orders placed you will see a table with all of the important information. To locate your status, view the Order Status which will list a brief description. If you purc Continue reading >>
A Nurses Review: Medtronic 670g Insulin Pump
Medtronic’s 670 G hybrid closed loop system is the smartest insulin pump to hit the market, and people living with type 1 diabetes, including my daughter and I, have been gobbling them up. As we embark into our second week on this new system, the majority of the time I’m all in, thinking: “This is amazing, I haven’t drank juice in days,” “I need to eat something – just to eat, not because I need to balance my diabetes,” “It’s so nice not to have T1D awaken me from sleep,” or “I feel less worried about my daughter.” All remarkable thoughts. A minority of the time, I’m thinking: “Why is this pump buzzing at me again?” “This algorithm isn’t really getting me into the 120 range,” “This sensor is frustrating – my Dexcom was so simplistic to use compared to this finicky Guardian 3 sensor,” “I wish I could calibrate anytime; there’s so much button pushing and user demand.” It’s not all peaches and cream – it’s a work in progress. Patience, I tell myself. It will get to know me better. Most people report that it takes a month to love the Medtronic 670G. Truth be told: I’m one week in, and I do love it 90% of the time – as does my 15 year old. Getting Started on the 670G We personally utilized the “Pathway Program” Medtronic offered through the end of April, 2017, placing us in a virtual line for the Medtronic 670G upgrade. We were fortunate enough to have purchased our pumps less than a year prior, so our out of pocket was expensive, but not unthinkable. Word has it that 50,000 customers have ordered the Medtronic 670G pump, but customers have faced hurdles along the way with the age of their current pumps and/or lack of insurance coverage for a new pump. Owning a pump that isn’t out of warranty means we’re at Continue reading >>
Bbb Business Profile | Medtronic Inc/diabetes | Reviews And Complaints
Medtronic Inc/Diabetes has received 1.33 out of 5 stars based on 4 Customer Reviews and a BBB Rating of F. Comprised of 67% BBB Rating and 33% Customer Review Rating. The BBB Customer Review Rating represents the customer's opinion of the business. The Customer Review Rating percentages are based on the total number of positive, neutral, and negative reviews posted. The BBB letter grade represents the BBB's opinion of how the business is likely to interact with its customers. The BBB grade is based on BBB file information about the business. In some cases, a business' grade may be lowered if the BBB does not have sufficient information about the business despite BBB's requests for that information from the business. The BBB Customer Review Rating plus the BBB Rating is not a guarantee of a business' reliability or performance. BBB recommends that consumers consider a business' BBB Rating and Customer Review Rating in addition to all other available information about the business. Continue reading >>
Medtronics Continuous Glucose Sensors On Backorder Again???
Medtronics Continuous Glucose Sensors on Backorder Again??? So I finally made the decision to use the Paradigm Continuous Glucose Monitoring System and am down to my last two sensors. I called Minimed yesterday to order another box and was told they are on backorder. I asked how long they had been on backorder and they said 2 weeks. Any idea when they might be in? Nope, sorry. GEEZ! Someone had mentioned before I upgraded that there was a backorder problem but it was finally worked out. Now when I need them, it's a backorder issue again. Anyone using these things that can tell me if this is an ongoing problem? Very frustrating. My endocrinologist would say this is simply a reflection of Medtronic's success. For me, it is another indication of Medtronic's inability to offer consistent service and reliable equipment to its customers. Medtronic has had in the past problems with billing, and equipment (the BD meter, Quickset Plus infusion sets, watertight I was a Medtronic customer. I am no longer a Medtronic customer (I have switched to the Cozmo pump). If I had to choose between multiple daily injections and Medtronic, I return to my five daily injections. My endocrinologist would say this is simply a reflection of Medtronic's success. For me, it is another indication of Medtronic's inability to offer consistent service and reliable equipment to its customers. Medtronic has had in the past problems with billing, and equipment (the BD meter, Quickset Plus infusion sets, watertight I was a Medtronic customer. I am no longer a Medtronic customer (I have switched to the Cozmo pump). If I had to choose between multiple daily injections and Medtronic, I return to my five daily injections. Much as I hate Medtronic's problems, I would never go back to injections. Several years a Continue reading >>
In Depth With Medtronic’s Chief Patient Officer
Hi! I’m Louis Dias, the Chief Patient Officer for Medtronic Diabetes. My job starts with listening to your needs and putting patient voices at the center of everything we do, including gathering insights to guide product development, designing better experiences, creating simpler products and services, engaging with you online and offline and everything in between. Mine is a role you don’t always see in other healthcare companies, so I think it speaks to the value we place on putting our patients’ lives, aspirations, and needs first. What made your team decide to sponsor the Beyond Type Run Team? Beyond Type Run really spoke to us because we’re just so inspired by what these runners are doing: living well with diabetes and taking on a big challenge. We’re inspired by the entire diabetes community and moved when you take on any type of adventure. These runners are a great example of that character we see among people with diabetes. They encourage others to take on their own personal challenge and earn that sense of accomplishment that’s really important for emotional wellbeing. This ties in really closely with what we’re about at Medtronic. We come to work every day because we’re inspired by the millions of people living with diabetes. You are the inspiration for new technologies like the MiniMedTM 670G system. Speaking of the MiniMed 670G system…how does it work? What makes it unique? The MiniMed 670G system is the world’s first hybrid closed loop system that automatically adjusts to your life. It consists of an advanced, waterproof insulin pump with a color screen, a continuous glucose monitor (CGM), and the advanced algorithms in our SmartGuard™ HCL technology. It helps you spend more time with your glucose levels in range by automatically determ Continue reading >>
2018 - New Year New Beginnings
Home Featured Posts Innovation New Year New Beginnings Posted by Louis Dias On January 18, 2018 In Featured Posts , Innovation A new year means new beginnings. I want to take this time to thank you for your patience with us over the last few months and share some very positive updates with you. As many of you know, an earlier-than-expected approval of the MiniMed 670G system with SmartGuard technology, unprecedented demand for our sensors and a treacherous hurricane ripping through Puerto Rico (where our manufacturing facility is located) all contributed to inventory challenges for us in 2017. I know how much you depend on this technology. And I can only imagine how frustrating and scary shipment delays and backorders can be. I sincerely apologize to all of you who have experienced this. Fortunately, today I have very good news to share: MiniMed 670G and MiniMed 630G systems are in stock and ready to meet demand. 99% of Priority Access orders have been fulfilled. Well be shipping the last few within the next month or so, barring a few exceptions for those with insurance issues (if this is you, well work with you individually). Those who order a MiniMed 670G system today will receive both the pump and CGM starter kit as soon as we receive insurance approval. If you have a recent order of Guardian Sensor 3 sensors, you should see no more than a 2-3 day delay as we catch up on existing orders. Enlite sensors are available and you should not experience order delays Want to learn more about the dedicated team in Puerto Rico working through the aftermath of Hurricane Maria to deliver your diabetes supplies? << Click here >>> Id also like to thank our dedicated team in Puerto Rico who have been working incredibly hard to upgrade our facility and processes to help prevent futu Continue reading >>
Medtronic Revenue Gets Burned By Hurricane And Fire
Editor's note: This story has been updated to include a statement from Medtronic. Medtronic said late last week that Hurricane Maria may have damaged its fiscal 2018 second-quarter revenue and non-GAAP net earnings by up to $250 million. As if that weren’t bad enough, the company now faces potential impact from the deadly wildfires tearing through Northern California. According to a Star Tribune report, Medtronic evacuated buildings in Santa Rosa, CA on Monday in response to the fires that have ravaged through the area. The company has four facilities in the Santa Rosa and the Sonoma County region that could be affected by the fires, according to the report. In an email to MDDI Qmed on Wednesday, Medtronic spokesperson Wendy Dougherty said the company's priority right now is the safety of Medtronic employees and their families who live in the area, many of whom are being evacuated. "On an ongoing basis, we are accounting for and keeping in contact with employees in the area. All facilities in the area are closed until further notice. Our thoughts are with our employees, their families, and the entire Sonoma and Napa communities impacted by the wildfires," Dougherty said. Monday's evacuation came just three days after Medtronic provided an update on the estimated financial impact from Hurricane Maria in the second quarter. While the company expects some non-recurring expenses directly related to the recovery efforts in Puerto Rico to be excluded from its non-GAAP earnings, expenses related to the impact outside of Puerto Rico will be considered operating expenses. It's too early to determine the ongoing impact, if any, from Hurricane Maria beyond the second quarter, Medtronic said. Each of Medtronic's four business groups has some level of manufacturing across four maj Continue reading >>
Newsroom | Medtronic | Rss Content
Medtronic Provides Update on Impact from Hurricane Maria DUBLIN - October 6, 2017 - Medtronic plc (NYSE: MDT) today provided an update on the impact to its manufacturing and sales operations as a result of Hurricane Maria. All four of the company's business groups have some level of manufacturing across four major locations in Puerto Rico. Considering the severity of the hurricane, the company's Puerto Rico facilities fared well, but each sustained some damage. Medtronic has made considerable progress in repairing its Puerto Rico manufacturing facilities, with limited production starting on October 2nd. Currently, all of its sites are partially operating, with the assistance of power from back-up generators, and manufacturing is expected to gradually ramp up over the coming weeks. The company continues to work with local and national government agencies, as well as power, communication, and logistics providers to fully restore its operations. In line with its business continuity protocols, the company is utilizing existing inventory levels and increasing manufacturing in locations outside of Puerto Rico for many of its products. Efforts to Support Medtronic's Puerto Rico Employees and the Puerto Rico Community Medtronic's main priority has been to verify the safety and status of its more than 5,000 direct and contract employees and their families and to aid in their well-being. The company has verified the well-being of more than 90 percent of its employee and contractor base, and most of these employees have returned to work. Medtronic is providing its employees and their immediate families with needed supplies, including water, food, power generators and other necessities. Medtronic formed the Medtronic Employee Emergency Assistance Fund to aid employees specifically Continue reading >>
Minimed Eshop | Medtronic-diabetes.com.au
The MiniMed eShop is a great online destination to buy products related to the management of diabetes. On the MiniMed eShop, you can: Browse and purchase a range of items including Sensors, Infusion Sets, Reservoirs, Cases, Pouches and lots more; Order your supplies at any time - day or night - using your credit card; Subscribe to deals, giving you savings & convenience with regularly scheduled shipments; Update and maintain your personal contact information; Create alternate shipping addresses for orders; How can I get in contact with someone at Medtronic? Our Customer Service Team is here for you on1800 777 808 (select option 2) toll free within Australia Monday - Friday from 9AM 5PM (AET). Alternatively, you can email: [email protected] If you urgently need to contact Medtronic in relation to faulty insulin pump or CGM device, please call our 24/7 Global Help Line on 1800 777 808 (select option 1). The easiest way to activate your MiniMed eShop account is by registering here . Your customer number can be found on any Medtronic invoices you may have received. If you are unsure of your Customer Number, or the email address we have on file, please contact our Customer Service Team on 1800 777 808 (select option 2). Im new to Medtronic Diabetes in Australia how do I create an account? The easiest way to register for the MiniMed eShop is to register here . You can either register as the Pump User or a Guardian. Registration should not take any longer than 10 minutes. Once submitted, account activation can sometimes take five minutes to process you will be emailed once your account is ready to use. How can I update personal or contact information? Once logged into the MiniMed eShop, simply navigate to My Account. In My Account youll be able to change all of Continue reading >>
Increased Demand Leads To Global Shortage Of Diabetes Equipment Component
Increased demand leads to global shortage of diabetes equipment component Increased demand leads to global shortage of diabetes equipment component A global shortage of a component used in conjunction with a popular brand of insulin pump has left some people resorting to older methods to test their blood sugar. Company working 'around the clock' to meet increased demand Posted: Aug 25, 2017 3:08 PM AT | Last Updated: August 25, 2017 Insulin pumps work by delivering insulin 24 hours a day through a catheter placed under the skin, giving Type 1 and Type 2 diabetes patients a little more flexibility in their routine compared with traditional injection methods. (The Associated Press) A global shortage of a component used in conjunction with a popular brand of insulin pump has left some people resorting to older methods to test their blood sugar. Medtronic, a Dublin-based medical technology development company, said a global surge in demand for their glucose sensor has lead to a "temporary disruption" in supply. "This shouldn't happen," said Mark Merrett of Dartmouth, N.S. "They should have saw it coming." The 37-year-old was diagnosed with Type 1 diabetes at 16. He has been using an insulin pump for over 10 years and the continuous glucose monitors (CGMs) for four or five years. Medtronic says it's working around the clock to meet demand for the sensors. (Associated Press) Insulin pumps work by delivering insulin 24 hours a day through a catheter placed under the skin, giving Type 1 and Type 2 diabetes patients a little more flexibility in their routine compared with traditional injection methods. The devices know how much insulin to release and how often because of a tiny electrode sensor placed below the skin that continuously measures the amount of glucose in the blood. Continue reading >>
Medtronic And Meters/backorder
This site uses cookies. By continuing to use this site, you are agreeing to our use of cookies. Learn More. We got our new MM Revel pump back in august. the meter didn't come with it. I called and ordered it that day and its still on backorder. called friday and they said it would probably be here late oct? Has anyone else experieinced this? just seems weird that the meters are that much on back order We just used the meter we had. We use the NovaMax (they bought out BD), so it reads to our pump. If you call them, they will send a meter out to you right away. call your rep, they should be able to give you a meter right away. Thats how I got two of them. One from our rep, and one from a diabetic fair, the rep there just gave matt another. Perhaps your dr office will have one for you as well. matts pump (522) holds three meters at a time. So one is kept at school, one for home, and one for his take about kit. Don't feel bad. When we got our pump from medtronic last month it came with 5 boxes of reservoirs for the larger pump, the wrong infusion sets and no meter. Took our educator a few minutes to realize why the reservoir wasn't going all the way into the pump. I called my medtronic rep - apparently everything was on backorder. Still not sure who thought sending the wrong reservoirs would somehow make up for that.... I would definitely check with your endo's office or your rep - I got a spare from my rep and I have seen freebies at my endo's office before. I will double check my box but I could swear they sent us a meter with the new pump that was delivered 1 1/2 weeks ago. Actually I am sure because I remember thinking I don't have any One Touch strips to go with the meter and there were none in the box of supplies. Hmmm...we got our revel in August and it came with th Continue reading >>
Cgm Sensor Delays Plaguing Medtronic | Diabetesmine
We're sorry, an error occurred. We are unable to collect your feedback at this time. However, your feedback is important to us. Please try again later. Not surprisingly, there's been a lot of hype about Medtronic's new 670G "hybrid closed loop" semi-automated insulin delivery system since it was approved by the FDA just over a year ago. After all, it's the first of its kind -- so far the only "pre-Artificial Pancreas" technology connecting an insulin pump and continuous glucose monitor with smart algorithms that's gotten the green light from regulators, much quicker than anyone expected in fact. Truly, there's a lot to be exited about. Yet despite all the good vibes (and mostly good press), Medtronic has faced a number of speed bumps over the past year -- from the company's slower-than-announced rollout that left many would-be customers frustrated, its inability to keep up with the high demand for CGM sensors and other supplies, to Anthem's initial refusal to cover the 670G, and Hurricane Maria in September hobbling Medtronic's Puerto Rico manufacturing operations. Of course any company can be hit with operational snags, or be affected by a natural disaster. But what makes this particularly alarming for the D-Community is the contracting of the diabetes device market these days, with a Nov. 12 Star Tribune story noting that some now see Medtronic as the "only game in town" for some of these products. With the insulin pump market shrinking and access to diabetes necessities becoming more uncertain, Medtronic is edging ever closer to monopolizing this med-tech segment and that means people with diabetes may not have many options except to make do. Bottom line: Many patients face fewer choices, and are afraid of being left twisting in the wind if they can't even get acces Continue reading >>
